https://european-biotechnology.net/wp-content/uploads/2025/01/Ceres_1000_F_170601825_EZ3TKHMkkO1IXUMXkIg88JecXAv0Y64c.jpg
562
1000
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-01-23 14:13:202025-01-23 14:13:20Ceres Brain Therapeutics announces €6m financing
https://european-biotechnology.net/wp-content/uploads/2025/01/medix_biochemica_brand_labs_KP-7965-e1737555597972.jpg
541
960
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-01-22 14:48:362025-01-22 14:48:36Medix Biochemica acquires CANDOR Bioscience
https://european-biotechnology.net/wp-content/uploads/2025/01/Arctic_Therapeutics-e1737542077825-1030x484-1.png
484
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-01-22 10:37:442025-01-22 10:37:44Arctic Therapeutics ASA kicks off with €26.5m Series A round
https://european-biotechnology.net/wp-content/uploads/2025/01/von-der-Leyen-EB-e1737376382539-1030x580-1.jpg
580
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-01-20 12:33:432025-01-20 12:33:43EuropaBio calling for EU Biotech Act
https://european-biotechnology.net/wp-content/uploads/2025/01/Obesity_1000_F_1032372571_WBcOKAJAO16RLrU3b6BseQaQ7HhehNbW-e1737361444142.jpg
560
963
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-01-20 09:56:512025-01-20 09:56:51PRAC: Semaglutide linked to rare eye disease?
https://european-biotechnology.net/wp-content/uploads/2025/01/inflarx_antiko__rper-web.webp
540
960
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-01-16 14:36:222025-01-16 14:36:22InflaRx secures European Commission approval for ARDS drug
https://european-biotechnology.net/wp-content/uploads/2025/01/Lungen-Image-by-David_SMC-from-Pixabay.png
540
960
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-01-16 14:34:462025-01-16 14:34:46Synairgen raises £18m for Phase 2 INVENT trial of SNG001
https://european-biotechnology.net/wp-content/uploads/2025/01/caplyta_By-Vaccinationist-Wikipedia-1030x385-1.png
385
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-01-15 08:06:332025-01-15 08:06:33Johnson & Johnson acquires Intra-Cellular Therapies for $14.6 billion
https://european-biotechnology.net/wp-content/uploads/2025/01/nasal_spray_robin_24-Wikipedia.jpg
540
960
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-01-13 14:32:212025-01-13 14:32:21Leyden Labs secures $70M to advance intranasal antibody therapies
https://european-biotechnology.net/wp-content/uploads/2025/01/gr3_lrg-1030x730-1.jpg
730
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-01-13 08:42:232025-01-13 08:42:23First in vivo CAR gene therapy trial in Europe approved
Scroll to top
